Announcements Trials
Browse Landscape

Phase

Phase NA 72Phase 3 9Phase EARLY_PHASE1 2Phase 4 2Phase 2 2Phase 1/2 1Phase 1 1

Status

Active not recruiting 4Recruiting 2Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Neoplasms 1Depression 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Counseling × Clear all
NCT03367923 2023-11-28

Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors

Stanford University

Phase 2 Completed
47 enrolled
Gynecologic

Endometrial Neoplasms

NCT01748734 2015-06-04

Cognitive Therapy in Reducing Depression in Patients With Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
25 enrolled

Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡